Treatment Options, Costs & Prognosis
Comprehensive guide to meds for Cushing's disease in dogs, including trilostane, mitotane, costs, side effects, diagnosis, and long-term prognosis.
If your dog has been drinking excessively, urinating indoors despite years of reliable house training, and developing a pot-bellied appearance, your veterinarian may have mentioned a condition called hyperadrenocorticism — commonly known as Cushing's disease. This endocrine disorder occurs when the adrenal glands produce too much cortisol, either because of a tumor on the pituitary gland (80-85% of cases), a tumor on the adrenal gland itself (15-20%), or prolonged exposure to steroid medications (iatrogenic Cushing's). It affects an estimated 1 to 2 out of every 1,000 dogs per year, making it one of the most common hormonal diseases in middle-aged and older dogs.
Finding the right meds for Cushing's disease in dogs requires understanding which form your dog has, because treatment paths differ dramatically. This guide walks through the medications, diagnostics, costs, and realistic outcomes you can expect — so you can have an informed conversation with your veterinarian about the best plan for your dog.
What Is Cushing's Disease in Dogs?
Cushing's disease is a chronic hormonal condition where the body produces excessive amounts of cortisol — the stress hormone that regulates metabolism, immune response, and blood pressure. In a healthy dog, the hypothalamus signals the pituitary gland, which then signals the adrenal glands to release cortisol. When this feedback loop breaks down, cortisol floods the system unchecked.
There are three recognized forms:
- Pituitary-dependent hyperadrenocorticism (PDH): A benign tumor (adenoma) on the pituitary gland overproduces ACTH, which overstimulates both adrenal glands. Accounts for 80-85% of naturally occurring cases.
- Adrenal-dependent hyperadrenocorticism (ADH): A tumor on one adrenal gland autonomously secretes cortisol. Roughly 50% of these tumors are malignant (adenocarcinomas). Accounts for 15-20% of cases.
- Iatrogenic Cushing's: Caused by long-term administration of corticosteroid medications (prednisone, dexamethasone, etc.) for allergies, autoimmune conditions, or other diseases.
Symptoms Checklist: Early Warning Signs vs. Advanced Signs
Cushing's disease is notorious for its slow, insidious onset. Many owners don't notice changes until several symptoms have accumulated over months. Use this checklist to track what you're observing at home and share it with your veterinarian.
| Severity | Symptom | What to Watch For |
|---|---|---|
| Early / Mild | Increased thirst (polydipsia) | Drinking more than 100 mL/kg/day — water bowl empties noticeably faster |
| Increased urination (polyuria) | Accidents indoors, needing more frequent outdoor breaks, larger urine volume | |
| Increased appetite (polyphagia) | Scavenging, begging, eating non-food items, seeming constantly hungry | |
| Mild panting | Panting at rest or in cool temperatures without exertion | |
| Restlessness at night | Pacing, inability to settle, waking to drink water | |
| Moderate | Pot-bellied appearance | Abdominal distension with visible rib thinning — "barrel" body shape |
| Bilateral symmetric hair loss | Thinning on flanks, trunk, and thighs — head and legs usually spared | |
| Thin, fragile skin | Skin tears easily, slow wound healing, visible blood vessels | |
| Muscle wasting | Visible spine/hip bones, weakness climbing stairs, difficulty jumping | |
| Recurrent skin/ear infections | Hot spots, yeast infections, bacterial folliculitis that keep returning | |
| Darkened skin patches | Hyperpigmentation on belly and inner thighs | |
| Advanced / Severe | Calcinosis cutis | Hard, gritty, calcium-encrusted plaques on the skin — often along the back |
| Neurological signs | Disorientation, head pressing, seizures, circling (suggests macroadenoma) | |
| Pulmonary thromboembolism | Sudden difficulty breathing, collapse — a life-threatening complication | |
| Diabetes mellitus | Comorbid insulin resistance — occurs in roughly 10-15% of Cushing's dogs | |
| Severe lethargy / collapse | Adrenal crisis (especially during mitotane treatment) — requires emergency care |
Risk Factors: Which Dogs Are Most Susceptible?
Breed Predisposition
According to the American Kennel Club, the breeds most frequently diagnosed with Cushing's disease include:
- Poodles (all sizes, especially Miniature and Toy)
- Dachshunds
- Small Terriers (Yorkshire, Boston, Cairn, West Highland White)
- Beagles
- Cocker Spaniels
- Boxers (higher risk for adrenal tumors specifically)
- German Shepherds
Age
Most dogs are diagnosed between 7 and 12 years old. The average age at diagnosis is approximately 10-11 years for PDH and 11-12 years for ADH. Cases in dogs under 5 are rare and warrant investigation for atypical causes.
Sex
Female dogs are slightly overrepresented, with a roughly 3:1 female-to-male ratio in some studies, though this varies by breed and study population.
Weight and Size
Small and medium breeds are disproportionately affected by PDH. Larger breeds (over 44 lb / 20 kg) have a higher relative risk for adrenal tumors (ADH).
Medication History
Any dog receiving long-term corticosteroid therapy — oral prednisone, injectable dexamethasone, topical steroid creams, or steroid-containing ear/eye drops — is at risk for iatrogenic Cushing's. Even "low-dose" maintenance protocols can trigger the condition over months to years.
How Veterinarians Diagnose Cushing's Disease
Diagnosing Cushing's is one of the more complex endocrine workups in veterinary medicine. No single test is definitive on its own — your vet will use a combination of screening tests and differentiating tests. Here's the typical diagnostic pathway and what to expect in costs (national averages for 2025-2026).
- Initial blood work and urinalysis ($150-$300): A complete blood count (CBC), serum biochemistry panel, and urinalysis often reveal patterns suggestive of Cushing's — elevated alkaline phosphatase (ALP), elevated cholesterol, dilute urine (low specific gravity), and sometimes elevated blood glucose. These findings are not diagnostic on their own but raise clinical suspicion.
- Urine cortisol:creatinine ratio ($50-$100): A morning urine sample collected at home (before any stress of a clinic visit). A normal result effectively rules out Cushing's. An elevated result means further testing is needed — it does not confirm the disease, as stress and other illnesses can also elevate this ratio.
- Low-dose dexamethasone suppression test (LDDST) ($200-$400): The most commonly used screening test. Your dog receives a small injection of dexamethasone, and blood cortisol levels are measured at baseline, 4 hours, and 8 hours. In a healthy dog, dexamethasone suppresses cortisol production. In a Cushing's dog, cortisol remains elevated. This test has approximately 85-95% sensitivity for PDH and can also help differentiate PDH from ADH based on the 4-hour and 8-hour patterns.
- ACTH stimulation test ($150-$350): Synthetic ACTH is injected, and cortisol is measured before and 1 hour after. This test has lower sensitivity (~60-65% for PDH) but higher specificity, and is the preferred test for diagnosing iatrogenic Cushing's and for monitoring treatment response once medication has started.
- High-dose dexamethasone suppression test (HDDST) ($200-$350): Used to differentiate PDH from ADH when the LDDST is inconclusive. PDH tumors typically (but not always) suppress with high-dose dexamethasone; adrenal tumors do not. This test is falling out of favor in some practices in favor of imaging.
- Abdominal ultrasound ($300-$600): Visualizes the adrenal glands directly. Bilaterally enlarged adrenals suggest PDH. A single enlarged adrenal with a contralateral atrophied adrenal strongly suggests ADH. Also screens for metastatic disease and evaluates liver architecture.
- CT or MRI ($1,000-$2,500): Recommended when neurological signs are present (suggesting a pituitary macroadenoma — a tumor larger than 10 mm) or when surgical planning for an adrenalectomy is needed. Not required for every case.
- Endogenous ACTH level ($80-$150, sent to reference lab): Measures the dog's own ACTH production. High ACTH indicates PDH; low/suppressed ACTH indicates ADH. Helpful for differentiation but has a longer turnaround time (1-2 weeks).
Medications for Cushing's Disease in Dogs
The two FDA-approved medications for treating pituitary-dependent Cushing's disease in dogs are trilostane and mitotane. Both require lifelong administration and careful monitoring. Your veterinarian will determine which medication is appropriate based on your dog's specific form of Cushing's, overall health, and your ability to manage the treatment protocol.
| Feature | Trilostane (Vetoryl®) | Mitotane (Lysodren®) |
|---|---|---|
| Mechanism | Inhibits 3β-hydroxysteroid dehydrogenase, blocking cortisol synthesis in the adrenal cortex | Selectively destroys the zona fasciculata and zona reticularis of the adrenal cortex (adrenocorticolysis) |
| FDA Approval | Approved 2008 — currently the first-line treatment | Approved for canine Cushing's; also used off-label historically |
| Dosing Frequency | Once or twice daily with food (twice daily preferred for more consistent cortisol control) | Initial loading phase: daily for 5-10 days; maintenance: 1-2 times per week |
| Typical Starting Dose | 2-6.7 mg/kg once daily, or 1-3 mg/kg twice daily (your vet will calculate based on weight and capsule sizes available) | 50 mg/kg/day divided BID during loading phase; maintenance at 50 mg/kg once or twice weekly |
| Time to Symptom Improvement | Reduced drinking/urination within 1-2 weeks; coat improvement may take 3-6 months | Reduced drinking/urination within 1-2 weeks during loading phase |
| Monitoring Schedule | ACTH stimulation test at 10-14 days, 30 days, 90 days, then every 3-6 months | ACTH stimulation test at end of loading phase, then periodically; owners must watch closely for signs of Addisonian crisis |
| Key Side Effects | Vomiting, diarrhea, lethargy, decreased appetite; rare adrenal necrosis | Vomiting, diarrhea, lethargy, anorexia, weakness; risk of permanent Addison's disease (hypoadrenocorticism) if over-treated |
| Cost (Monthly) | $50-$200/month depending on dog size and capsule strength | $30-$100/month (cheaper drug, but loading phase requires more vet visits) |
| Available Capsule Sizes | Vetoryl: 10 mg, 30 mg, 60 mg, 120 mg. Generic trilostane also available. | 500 mg tablets (scored); compounded formulations available for smaller dogs |
| Reversibility | Effects are reversible — if stopped, cortisol production resumes within 24-48 hours | Adrenal destruction is partially or fully irreversible — risk of permanent Addison's disease |
Additional and Supportive Medications
Beyond the primary Cushing's medications, your veterinarian may prescribe additional drugs to manage complications or support treatment:
- Selegiline (Anipryl®): An MAO-B inhibitor sometimes used for mild PDH cases, particularly when owners cannot manage the monitoring requirements of trilostane or mitotane. Less effective than first-line options — clinical improvement reported in roughly 40-70% of dogs, but it does not normalize cortisol levels or address the underlying adrenal overstimulation. May help with cognitive/behavioral symptoms associated with Cushing's.
- Insulin: For the approximately 10-15% of Cushing's dogs that develop concurrent diabetes mellitus. Insulin requirements may change as Cushing's treatment stabilizes cortisol levels.
- Antibiotics/antifungals: For recurrent secondary skin and ear infections caused by immune suppression from excess cortisol.
- Blood pressure medications: Systemic hypertension is common in Cushing's dogs and may require amlodipine or other antihypertensives.
- Liver support supplements: S-adenosylmethionine (SAMe, e.g., Denamarin®) may be recommended if liver enzymes are significantly elevated.
Surgical Options
For dogs with adrenal-dependent Cushing's (ADH), surgical removal of the affected adrenal gland (adrenalectomy) can be curative if the tumor is benign and has not metastasized. Success rates for benign adrenal adenomas range from 70-90% with experienced surgeons. Malignant adrenal tumors (adenocarcinomas) have a poorer prognosis due to metastatic spread — median survival times of approximately 12-18 months post-surgery have been reported in some studies.
Adrenalectomy is a complex surgery performed at specialty centers. Costs typically range from $3,000-$7,000 including pre-surgical imaging, the procedure, and post-operative care. Dogs require temporary cortisol supplementation after surgery while the remaining adrenal gland recovers function.
For pituitary macroadenomas causing neurological signs, radiation therapy (stereotactic radiosurgery or conventional fractionated radiation) may be recommended. This is available at a limited number of veterinary oncology centers and costs $5,000-$10,000+.
Prognosis and Life Expectancy
The prognosis for Cushing's disease depends heavily on the form, stage at diagnosis, and how well the condition responds to treatment.
| Form / Stage | Median Survival Time | Key Factors |
|---|---|---|
| PDH — well-managed with trilostane | 2-2.5 years (many dogs live 3-5+ years with good control) | Consistent medication, regular monitoring, no macroadenoma |
| PDH — with pituitary macroadenoma | 6-22 months depending on tumor size and neurological involvement | Radiation therapy may improve outcomes; neurological signs worsen prognosis |
| ADH — benign adenoma, surgically removed | 18 months to 4+ years (potentially curative) | Complete surgical excision; no metastasis at diagnosis |
| ADH — malignant adenocarcinoma | 6-18 months | Metastatic spread (liver, lungs); surgical margins; vascular invasion |
| Iatrogenic Cushing's | Depends on underlying condition requiring steroids | Gradual steroid tapering; resolution of symptoms over weeks to months once steroids are withdrawn |
According to the Merck Veterinary Manual, most dogs with uncomplicated PDH respond well to medical management and enjoy a good quality of life for years after diagnosis. The leading causes of death in Cushing's dogs are not the disease itself but related complications: pulmonary thromboembolism, congestive heart failure, concurrent diabetes complications, and infections related to immune suppression.
Home Care, Daily Management, and Monitoring
Living with a Cushing's dog requires a structured daily routine and keen observation. Here's what successful long-term management looks like in practice:
Daily Medication Administration
- Give trilostane with food — this significantly improves absorption and reduces GI side effects.
- Administer at the same time(s) each day to maintain consistent cortisol suppression.
- If you miss a dose, give it when you remember unless it's close to the next scheduled dose. Never double-dose.
- Store Vetoryl capsules at room temperature, protected from moisture. Do not split or crush capsules — the powder inside can irritate skin (wear gloves if a capsule breaks).
At-Home Monitoring
- Track water intake: Measure how much water your dog drinks daily. A reduction in excessive drinking is often the first sign that medication is working. If drinking increases again, it may signal that the dose needs adjustment.
- Monitor appetite: A dramatic drop in appetite can indicate over-treatment (Addisonian crisis). Contact your vet if appetite decreases significantly.
- Watch for lethargy or weakness: While mild improvement in energy is expected as muscle strength returns, sudden lethargy, vomiting, or diarrhea is a red flag.
- Skin and coat progress: Photograph your dog's coat monthly. Hair regrowth is slow — expect 3-6 months before visible improvement. Calcinosis cutis lesions may take 6-12 months to resolve.
- Weight tracking: Weigh your dog monthly. Gradual weight normalization and reduction in abdominal distension are positive signs.
Lifestyle Adjustments
- Provide easy access to outdoor potty breaks — even well-managed Cushing's dogs may need more frequent opportunities to urinate.
- Maintain moderate, consistent exercise. Avoid sudden intense activity if your dog has significant muscle wasting.
- Avoid stressful situations when possible — stress triggers cortisol release, which can complicate management.
- Keep up with routine veterinary care including dental cleanings, parasite prevention, and vaccinations (your vet may adjust vaccine protocols based on your dog's immune status).
Veterinary Monitoring Schedule
Once your dog's medication dose is stabilized, expect ACTH stimulation testing every 3-6 months for life. Additional blood work (CBC, chemistry panel) is typically done at the same visits. Each monitoring visit with ACTH stim test costs approximately $150-$350.
Total Cost of Treatment: What to Budget
Cushing's disease is a significant financial commitment. Here's a realistic breakdown based on 2025-2026 veterinary pricing (costs vary by region — urban and specialty centers trend higher):
| Expense Category | Low Estimate | High Estimate | Frequency |
|---|---|---|---|
| Initial diagnostic workup | $500 | $2,000 | One-time (at diagnosis) |
| Advanced imaging (CT/MRI) | $1,000 | $2,500 | One-time (if needed) |
| Trilostane (Vetoryl) monthly | $50 | $200 | Monthly, ongoing |
| Mitotane (Lysodren) monthly | $30 | $100 | Monthly, ongoing |
| ACTH stim monitoring visit | $150 | $350 | Every 3-6 months |
| Adrenalectomy surgery (ADH) | $3,000 | $7,000 | One-time (if applicable) |
| Radiation therapy (macroadenoma) | $5,000 | $10,000+ | One-time (if applicable) |
| Emergency Addisonian crisis | $500 | $2,500 | As needed (unpredictable) |
| Supportive medications (insulin, antibiotics, etc.) | $30 | $200 | Monthly (if applicable) |
First-year total estimate (uncomplicated PDH with trilostane): $1,500-$4,500 including diagnosis, medication, and monitoring visits. Ongoing annual cost: $1,000-$3,500 per year for medication and monitoring. Pet insurance can offset a significant portion of these costs if the policy was purchased before diagnosis — check your plan's chronic condition coverage.
When to Call the Vet: Emergency Red Flags
🚨 Seek Immediate Veterinary Care If Your Dog Shows:
- Sudden vomiting and diarrhea — especially if on trilostane or mitotane (possible Addisonian crisis)
- Complete loss of appetite for more than 24 hours
- Extreme lethargy, inability to stand, or collapse
- Sudden difficulty breathing or rapid breathing at rest — possible pulmonary thromboembolism
- Seizures, disorientation, head pressing, or circling — possible pituitary macroadenoma expansion
- Marked increase in thirst/urination after being stable — may indicate dose failure or disease progression
- Signs of acute pain — vocalizing, trembling, hunched posture
For suspected toxic ingestion or medication overdose, contact:
ASPCA Animal Poison Control: (888) 426-4435 (24/7, consultation fee applies)
Pet Poison Helpline: (855) 764-7661 (24/7)
Always consult your veterinarian before making any changes to your dog's medication or treatment plan. This guide is for educational purposes and does not replace professional veterinary care.
Frequently Asked Questions
Can Cushing's disease in dogs be cured?
In most cases, no — pituitary-dependent Cushing's (the most common form) is managed, not cured. Dogs take medication for life and require ongoing monitoring. However, adrenal-dependent Cushing's caused by a benign tumor can potentially be cured with surgical removal of the affected adrenal gland. Iatrogenic Cushing's typically resolves once the causative steroid medication is gradually tapered and discontinued.
How much do meds for Cushing's disease in dogs cost per month?
Trilostane (Vetoryl) typically costs $50-$200 per month depending on your dog's size and the capsule strength needed. A 20 lb dog may need only a 30 mg capsule daily (~$60-$80/month), while a 70 lb dog might require 120 mg daily or split dosing (~$150-$200/month). Generic trilostane is available and can reduce costs by 20-40%. Mitotane is generally less expensive at $30-$100/month but requires more intensive monitoring during the loading phase.
What is the life expectancy of a dog with Cushing's disease?
With proper treatment and monitoring, most dogs with pituitary-dependent Cushing's live 2-5 years after diagnosis, and many live longer. The median survival time reported in veterinary literature is approximately 2-2.5 years for medically managed PDH, but individual outcomes vary widely based on age at diagnosis, comorbidities, and treatment response. Dogs with adrenal tumors that are successfully removed surgically may live 3-4+ years.
Are there natural or alternative treatments for Cushing's in dogs?
There is no scientifically validated natural cure for Cushing's disease. Some supplements (melatonin, lignans from flaxseed) have been studied for their mild cortisol-modulating effects, but evidence is limited and they are not substitutes for FDA-approved medications. Always discuss any supplements with your veterinarian, as some can interact with prescribed medications. Be cautious of online products claiming to "cure" Cushing's without veterinary oversight — unregulated treatments can delay proper care and worsen outcomes.
Which breeds are most prone to Cushing's disease?
Poodles (especially Miniature and Toy varieties), Dachshunds, small terriers (Yorkshire Terriers, Boston Terriers, Cairn Terriers), Beagles, Cocker Spaniels, Boxers, and German Shepherds are among the most commonly affected breeds. However, any breed can develop Cushing's disease, particularly in the 7-12 year age range.
Can I stop giving my dog's Cushing's medication if symptoms improve?
No. Symptom improvement means the medication is working, not that the disease is resolved. Stopping trilostane will cause cortisol levels to rise again within 24-48 hours, and symptoms will return. Stopping mitotane after the loading phase is part of the prescribed protocol (you switch to maintenance dosing), but complete discontinuation without veterinary guidance can lead to disease relapse. Always consult your veterinarian before making any changes to your dog's medication regimen.
Sources: Merck Veterinary Manual — Hyperadrenocorticism in Dogs; AKC — Cushing's Disease in Dogs; American Veterinary Medical Association (AVMA).
Beth Carrasco
All our authors care for dogs every day — read more of their work on the authors page.



